• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受手术治疗的胃癌患者5年和10年生存率的比较。评估5年生存率作为术后可治愈性的有效指标。

Comparison of 5- and 10-year survival rates in operated gastric cancer patients. Assessment of the 5-year survival rate as a valid indicator of postoperative curability.

作者信息

Koga S, Kaibara N, Kishimoto H, Nishidoi H, Kimura O, Okamoto T, Tamura H

出版信息

Langenbecks Arch Chir. 1982;356(1):37-42. doi: 10.1007/BF01270600.

DOI:10.1007/BF01270600
PMID:7054631
Abstract

To evaluate whether it is appropriate to estimate the postoperative curability of gastric cancer based on the 5-year survival rate, we compared 5- and 10-year survival rates in 477 primary gastric cancer patients who had undergone gastrectomy during the 8-year period from 1960-1967. In patients who had died more than 5 years after surgery, the cause of death was investigated. The 10-year survival rate of 315 curatively operated patients was 59.1%, 2.9% lower than the 5-year survival rate. Of 176 patients who survived more than 5 years postoperatively, only 9 (5.1%) died of cancer recurrence, suggesting that the 5-year survival rate adequately reflects the curative success of gastric cancer surgery. The postoperative curability of gastric cancer is usually estimated by the 5-year survival rate. However, even in patients who survived for more than 5 years postoperatively, cancer recurrence has been observed. Therefore, we deemed it useful to assess whether it is appropriate to estimate the postoperative curability of gastric cancer based on the 5-year survival rate. From this point of view, we compared the 5- and 10-year survival rates of operated primary gastric patients and investigated the cause of death in patients who died more than 5 years postoperatively. Furthermore, in patients with cancer recurrence more than 5 years postoperatively, the pathologic findings on the cancer in the originally resected specimen were re-evaluated.

摘要

为评估基于5年生存率来估计胃癌术后治愈率是否合适,我们比较了1960年至1967年这8年间477例接受胃切除术的原发性胃癌患者的5年和10年生存率。对于术后死亡超过5年的患者,调查其死亡原因。315例接受根治性手术患者的10年生存率为59.1%,比5年生存率低2.9%。在术后存活超过5年的176例患者中,只有9例(5.1%)死于癌症复发,这表明5年生存率充分反映了胃癌手术的治愈成功情况。胃癌的术后治愈率通常通过5年生存率来估计。然而,即使在术后存活超过5年的患者中,也观察到了癌症复发。因此,我们认为评估基于5年生存率来估计胃癌术后治愈率是否合适是有用的。从这个角度出发,我们比较了接受手术的原发性胃癌患者的5年和10年生存率,并调查了术后死亡超过5年患者的死亡原因。此外,对于术后5年以上出现癌症复发的患者,对最初切除标本中的癌症病理结果进行了重新评估。

相似文献

1
Comparison of 5- and 10-year survival rates in operated gastric cancer patients. Assessment of the 5-year survival rate as a valid indicator of postoperative curability.接受手术治疗的胃癌患者5年和10年生存率的比较。评估5年生存率作为术后可治愈性的有效指标。
Langenbecks Arch Chir. 1982;356(1):37-42. doi: 10.1007/BF01270600.
2
Role of surgery in the patients with stage I and II primary gastric lymphoma.手术在Ⅰ期和Ⅱ期原发性胃淋巴瘤患者中的作用。
Hepatogastroenterology. 2003 May-Jun;50(51):877-82.
3
Changes in postoperative recurrence and prognostic risk factors for patients with gastric cancer who underwent curative gastric resection during different time periods.不同时期行根治性胃切除术的胃癌患者术后复发变化及预后危险因素。
Ann Surg Oncol. 2013 Jul;20(7):2317-27. doi: 10.1245/s10434-012-2700-0. Epub 2013 May 16.
4
The risk to develop a recurrence of a gastric cancer-is it independent of time?胃癌复发的风险——它与时间无关吗?
Langenbecks Arch Surg. 2008 Mar;393(2):149-55. doi: 10.1007/s00423-007-0272-4. Epub 2008 Jan 4.
5
Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: a prospective with quality control 10-year follow-up study.基于病理浆膜和淋巴结的分类可准确预测胃癌复发风险和预后,并确定日式扩大手术对西方患者的潜在价值和局限性:一项具有质量控制的前瞻性10年随访研究。
Br J Cancer. 2001 Jun 15;84(12):1602-9. doi: 10.1054/bjoc.2001.1720.
6
[Gastric stump carcinoma: frequency, treatment, complications and prognosis].[残胃癌:发病率、治疗、并发症及预后]
Chirurg. 2017 Apr;88(4):317-327. doi: 10.1007/s00104-016-0296-9.
7
[Surgical therapy of stomach cancer-stagnation or progress? Results of 2665 stomach cancer patients].[胃癌的外科治疗——停滞还是进展?2665例胃癌患者的治疗结果]
Fortschr Med. 1982 Oct 28;100(40):1876-82.
8
Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.接受根治性胃切除术的胃癌患者中ADAM17表达的预后意义
Clin Transl Oncol. 2015 Aug;17(8):604-11. doi: 10.1007/s12094-015-1283-1. Epub 2015 Mar 19.
9
Surgical treatment of carcinoma of the gastric stump.胃残端癌的外科治疗
Br J Surg. 1991 Jul;78(7):822-4. doi: 10.1002/bjs.1800780718.
10
[Comparison of clinicopathological features and prognosis analysis between carcinoma in the remnant stomach and gastric cancer].残胃癌与胃癌的临床病理特征比较及预后分析
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 May 25;21(5):529-534.

引用本文的文献

1
Follow-Up and Strategies After Curative Surgical Resection for Gastric Cancer.
Korean J Helicobacter Up Gastrointest Res. 2025 Dec;25(4):336-341. doi: 10.7704/kjhugr.2025.0056. Epub 2025 Dec 4.
2
Proposed Models for Prediction of Mortality in Stage-I and Stage-II Gastric Cancer and 5 Years after Radical Gastrectomy.预测Ⅰ期和Ⅱ期胃癌及根治性胃切除术后5年死亡率的模型
J Oncol. 2022 Mar 8;2022:4510000. doi: 10.1155/2022/4510000. eCollection 2022.
3
Cost effectiveness analysis of population-based serology screening and (13)C-Urea breath test for Helicobacter pylori to prevent gastric cancer: a markov model.基于人群的血清学筛查和¹³C-尿素呼气试验预防胃癌的成本效益分析:马尔可夫模型

本文引用的文献

1
The general rules for The gastric cancer study in surgery.胃癌外科研究的一般规则。
Jpn J Surg. 1973 Mar;3(1):61-71. doi: 10.1007/BF02469463.
2
Clinical and pathologic evaluation of patients with recurrence of gastric cancer more than five years postoperatively.
Am J Surg. 1978 Sep;136(3):317-21. doi: 10.1016/0002-9610(78)90284-2.
World J Gastroenterol. 2008 May 21;14(19):3021-7. doi: 10.3748/wjg.14.3021.